WallStreetZenWallStreetZen

NASDAQ: GMAB
Genmab A Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for GMAB

Based on 3 analysts offering 12 month price targets for Genmab A

Min Forecast
$27.00+23.51%
Avg Forecast
$36.67+67.74%
Max Forecast
$46.00+110.43%

Should I buy or sell GMAB stock?

Based on 3 analysts offering ratings for Genmab A.

Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although GMAB's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates GMAB as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their GMAB stock forecasts and price targets.

GMAB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-08
lockedlocked$00.00+00.00%2025-04-09
lockedlocked$00.00+00.00%2025-02-13

1 of 1

Forecast return on equity

Is GMAB forecast to generate an efficient return?

Company
4.59%
Industry
167.48%
Market
90.13%
GMAB's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GMAB forecast to generate an efficient return on assets?

Company
3.69%
Industry
44.42%
GMAB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GMAB earnings per share forecast

What is GMAB's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$1.57-9.19%
Avg 2 year Forecast
$1.93+11.44%
Avg 3 year Forecast
$2.72+56.66%
GMAB's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

GMAB revenue forecast

What is GMAB's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$3.6B+14.03%
Avg 2 year Forecast
$4.3B+37.56%
Avg 3 year Forecast
$5.0B+59.36%
GMAB's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GMAB earnings growth forecast

How is GMAB forecast to perform vs Biotechnology companies and vs the US market?

Company
14.38%
Industry
9.74%
Market
15.81%
GMAB's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
GMAB's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
GMAB's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

GMAB revenue growth forecast

How is GMAB forecast to perform vs Biotechnology companies and vs the US market?

Company
16.9%
Industry
56.77%
Market
10.4%
GMAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GMAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GMAB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GMAB$21.86$36.67+67.74%Strong Buy
INCY$70.34$73.73+4.82%Hold
UTHR$300.16$357.43+19.08%Buy
MRNA$34.28$39.22+14.42%Hold
EXEL$45.17$44.53-1.41%Buy
View Top Biotech Stocks

Genmab A Stock Forecast FAQ

Is Genmab A Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: GMAB) stock is to Strong Buy GMAB stock.

Out of 3 analysts, 1 (33.33%) are recommending GMAB as a Strong Buy, 2 (66.67%) are recommending GMAB as a Buy, 0 (0%) are recommending GMAB as a Hold, 0 (0%) are recommending GMAB as a Sell, and 0 (0%) are recommending GMAB as a Strong Sell.

If you're new to stock investing, here's how to buy Genmab A stock.

What is GMAB's earnings growth forecast for 2025-2027?

(NASDAQ: GMAB) Genmab A's forecast annual earnings growth rate of 14.38% is forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 9.74%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.81%.

Genmab A's earnings in 2025 is $1,107,660,000.On average, 8 Wall Street analysts forecast GMAB's earnings for 2025 to be $104,174,603, with the lowest GMAB earnings forecast at $81,422,610, and the highest GMAB earnings forecast at $121,802,929. On average, 8 Wall Street analysts forecast GMAB's earnings for 2026 to be $127,846,737, with the lowest GMAB earnings forecast at $90,028,252, and the highest GMAB earnings forecast at $153,577,606.

In 2027, GMAB is forecast to generate $179,725,517 in earnings, with the lowest earnings forecast at $155,563,523 and the highest earnings forecast at $205,873,429.

What is GMAB's revenue growth forecast for 2025-2027?

(NASDAQ: GMAB) Genmab A's forecast annual revenue growth rate of 16.9% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.77%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.4%.

Genmab A's revenue in 2025 is $3,148,620,000.On average, 7 Wall Street analysts forecast GMAB's revenue for 2025 to be $237,678,093,312, with the lowest GMAB revenue forecast at $230,895,987,072, and the highest GMAB revenue forecast at $247,445,298,072. On average, 7 Wall Street analysts forecast GMAB's revenue for 2026 to be $286,723,697,588, with the lowest GMAB revenue forecast at $266,973,485,052, and the highest GMAB revenue forecast at $304,692,674,683.

In 2027, GMAB is forecast to generate $332,153,542,201 in revenue, with the lowest revenue forecast at $305,963,661,768 and the highest revenue forecast at $348,991,870,368.

What is GMAB's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: GMAB) forecast ROA is 3.69%, which is lower than the forecast US Biotechnology industry average of 44.42%.

What is GMAB's Price Target?

According to 3 Wall Street analysts that have issued a 1 year GMAB price target, the average GMAB price target is $36.67, with the highest GMAB stock price forecast at $46.00 and the lowest GMAB stock price forecast at $27.00.

On average, Wall Street analysts predict that Genmab A's share price could reach $36.67 by Jul 8, 2026. The average Genmab A stock price prediction forecasts a potential upside of 67.74% from the current GMAB share price of $21.86.

What is GMAB's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: GMAB) Genmab A's current Earnings Per Share (EPS) is $1.73. On average, analysts forecast that GMAB's EPS will be $1.57 for 2025, with the lowest EPS forecast at $1.23, and the highest EPS forecast at $1.84. On average, analysts forecast that GMAB's EPS will be $1.93 for 2026, with the lowest EPS forecast at $1.36, and the highest EPS forecast at $2.32. In 2027, GMAB's EPS is forecast to hit $2.72 (min: $2.35, max: $3.11).

What is GMAB's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: GMAB) forecast ROE is 4.59%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.